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Neuroimaging studies have revealed significant reductions in the gray matter (GM) of sev-
eral brain regions in patients with schizophrenia, a neuropsychiatric disorder with high
hereditability. However, it is unclear whether unaffected relatives have GM abnormalities
in common with their affected relatives, which may relate to susceptibility to develop-
ing schizophrenia. To address this issue, we conducted two separate meta-analyses of
voxel-based morphometry to investigate GM abnormalities in schizophrenia patients and
their unaffected relatives. One meta-analysis compared a patient group with healthy con-
trols, whereas the other meta-analysis compared the unaffected relatives with healthy
controls. Eight studies comprising 495 patients with schizophrenia, 584 unaffected rela-
tives of patients, and 596 healthy controls were systematically included in the present
study. Compared to healthy controls, the patient group showed decreased GM in the right
cuneus, the right superior frontal gyrus, the right insula and the left claustrum, and increased
GM in the bilateral putamen, the right parahippocampal gyrus, the left precentral gyrus,
the left inferior temporal gyri, and the right cerebellar tonsil. The comparison between
unaffected relatives and healthy controls showed a GM reduction in the left claustrum, the
bilateral parahippocampal gyri, the left fusiform gyrus, the right inferior temporal gyrus, and
the bilateral medial prefrontal cortices, whereas increased GM was observed in the right
hippocampus, the right fusiform gyrus, the right precentral gyrus, and the right precuneus.
Thus, our meta-analyses show that the GM changes in schizophrenia patients and their
unaffected relatives are largely different, although there is subtle overlap in some regions.
Keywords: schizophrenia, unaffected relatives, MRI, voxel-based morphometry, gray matter, meta-analysis
INTRODUCTION
Anatomical brain abnormalities have been well established
in schizophrenia (1, 2). However, the molecular mechanism
that underlies anatomical brain abnormalities in schizophrenia
remains unclear, and an important question is whether these
abnormalities are related to the illness itself or are linked to genetic
risk, as an endophenotype (3). Characterizing endophenotypes
is a compelling venture because endophenotypes may represent
less complex disease antecedents that are easier to study than the
illness syndrome itself. As many brain structures are highly heri-
table (4) and are influenced by genetic variants that are beginning
to emerge in large-scale studies (5), brain structures may be a
good endophenotype (3). Previous studies of unaffected relatives
of schizophrenia patients demonstrated gray matter (GM) abnor-
malities that were similar but less pronounced than those in the
patients, suggesting that the abnormalities are related to genetic
susceptibility to the disorder (6, 7).
The majority of previous morphometric studies, however, stud-
ied schizophrenia patients and their unaffected relatives sepa-
rately. Decreased GM volume in the left superior temporal gyrus
and the left medial temporal lobe were the most common find-
ings in the comparative studies of patients with schizophrenia
and healthy controls with no personal or family history of psy-
chosis (2). However, the results observed in such comparisons
may reflect a complex combination of multiple causes, such as
genetics, substance abuse, environmental factors, obstetric com-
plications and birth injuries (8, 9), and other factors secondary to
the illness. Indeed, whether these changes are the result of the use
of antipsychotic medication or the severity of the illness itself is
a matter of debate. However, studying unaffected relatives avoids
the confounding factors of chronicity and antipsychotic medica-
tion. Furthermore, this population is independent of psychosis,
thus avoiding the possible neurotoxic effects of psychosis, which
may be present even in high-risk populations. Finally, a focus on
unaffected relatives makes it possible to study genetic factors and
environmental factors with respect to their roles in schizophre-
nia etiology (1). The most commonly reported abnormal brain
region in unaffected relatives is the hippocampus, which was con-
firmed in a meta-analysis of non-psychotic first-degree relatives
of schizophrenia patients (10). However, it should be noted that
the hippocampus is also one of the most commonly investigated
brain regions in studies of unaffected relatives of schizophrenia
patients using region-of-interest (ROI) analysis. Only a few stud-
ies have employed whole-brain data-driven unbiased methods,
such as voxel-based morphometry (VBM), which performs voxel-
wise comparisons of gray and white matter probabilities between
groups of subjects. The most common findings in whole-brain
comparison studies comparing unaffected relatives with healthy
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controls involve the left putamen/globus pallidus (basal ganglia),
the amygdala, and the parahippocampal gyrus (11), which are
similar to the results of studies involving patients. However, one
important problem with independent studies of patients and unaf-
fected relatives is that the patients and unaffected relatives are not
biologically related; thus, one cannot conclude from these studies
whether the patients share anatomical deficits with their unaf-
fected relatives. Only a few studies have explored whole-brain
anatomical deficits in both patients and their unaffected biolog-
ical relatives (6, 7, 12–17), but the findings are inconsistent. Hu
et al. (17) found that untreated patients with first-episode schiz-
ophrenia and their unaffected siblings shared decreases of GM in
the left middle temporal gyrus. A study of discordant monozy-
gotic twins found that non-psychotic twins showed no significant
differences in regional GM relative to the healthy control twins,
although twins with schizophrenia had smaller GM in the insula,
superior/medial frontal, pre/postcentral, cingulate, and superior
temporal gyri compared to healthy control twins (13). Negative
results of GM in first-degree relatives were also found in another
study (12), though patients with schizophrenia reported reduced
GM primarily in the anterior cingulate gyrus and the insula. In
an optimized VBM study, Honea et al. (14) investigated a large
group of patients and their unaffected siblings and found that
siblings tended to share GM decreases in the medial frontal, supe-
rior temporal, and insular cortices with their affected siblings,
but these decreases were not significant after multiple comparison
correction.
Thus, the aims of the present meta-analysis were to determine
whether schizophrenia patients and their unaffected biological rel-
atives have GM abnormalities and if so, to map the common and
the different alterations of GM between both groups.
MATERIALS AND METHODS
SELECTION PROCEDURES
Studies were selected using a systematic search strategy. Two
independent researchers conducted a two-step literature review
process. First, we performed a database search to find putative
VBM studies. The keywords included (1) schizophrenia, (2) fam-
ilies or relatives or sibling or parents or offspring or twins, (3)
structural MRI, (4) VBM or voxel-based analysis. These items
were entered in various combinations when searching. Only arti-
cles published in print or online before July 2013 in English were
selected using two databases (Pubmed and Medline). Second, the
reference lists of the selected articles and similar studies were
manually checked for additional studies that fit these criteria but
that were not identified by our computerized searching process.
We included all studies that met the following criteria: (a) an
original paper in a peer-reviewed journal; (b) investigating GM
volume or GM density/concentration by VBM at the whole-brain
level among schizophrenia patients, their relatives or siblings and
healthy controls; and (c) use of Montreal Neurological Institute
(MNI) or Talairach coordinates in the VBM analyses. Studies that
had overlapping samples were excluded. Studies lacking biolog-
ical relatives of patients with schizophrenia were also excluded.
The relatives investigated in each study were supposed to come
from the studied patients’ own families, not from other families
with a history of schizophrenia. We contacted the corresponding
authors for details required for the present meta-analysis. In our
present meta-analysis, Meta-analysis Of Observational Studies in
Epidemiology (MOOSE) guidelines are followed (18).
VOXEL-BASED META-ANALYSIS
Prior to conducting the voxel-based meta-analysis, we extracted
peak coordinates resulting from VBM analyses across the whole-
brain and then excluded those coordinates using partial coverage,
ROIs, or small volume correction (SVCs). This approach ensured
that the studies we collected were comparable and that their pur-
pose was to localize GM alterations across the entire cortex. Within
each included study, the same statistical threshold used through-
out the whole-brain was carefully checked to avoid biases toward
liberally thresholded brain regions, as it is not uncommon in neu-
roimaging studies that the statistical thresholds for some ROI are
more liberal than for the rest of the brain (19).
The Effect-Size Signed Differential Mapping (ES-SDM)
(http://www.sdmproject.com/software), which is a new version of
SDM, was chosen as our primary meta-analytical software (20).
ES-SDM has several advantages over other voxel-based methods.
First, the criterion that ES-SDM uses for selecting reported peak
coordinates is so strict that it ensures that only regions with sta-
tistical significance at the whole-brain level will be considered in
the meta-analysis, which prevents biases resulting from methods
using liberal thresholds and ROI methods in neuroimaging studies
(19). Second, previous methods such as activation likelihood esti-
mation (ALE) (21) and multilevel kernel density analysis (MKDA)
(22) only need reported peak coordinates. As for the ES-SDM, the
use of effect-size enables combination of reported peak coordi-
nates with statistical parametric maps allowing more detailed and
accurate meta-analysis (20). Third, to avoid any voxel appearing
significant in opposite directions, ES-SDM permits the represen-
tation of both GM increases and decreases in the same map. Last,
complementary analyses such as jack-knife, subgroup, and meta-
regression analyses are readily used to assess the robustness and
heterogeneity of the results (20).
Two meta-analyses were conducted separately to describe dif-
ferences in GM between patients and healthy controls and between
relatives and healthy controls. A Gaussian kernel of 20 mm half-
width was employed to assign indicators of proximity to the
reported coordinates as it can optimally balance sensitivity and
specificity in ES-SDM (20). A systematic voxel-based leave-one-
out jack-knife analysis was also conducted to test the replicability
of the results in various combinations of the included studies.
The findings might be highly conclusive and replicable if previ-
ous significant ES-SDM results could be replicated in all or most
study combinations. The standard ES-SDM thresholds (uncor-
rected P < 0.005, extent threshold of clusters >10 voxels) which
were proposed to optimally balance the sensitivity and specificity
and to be an approximate equivalent to corrected P-value= 0.05
in ES-SDM for effect-size were used (20).
RESULTS
INCLUDED STUDIES
The search flow diagram is shown in Figure 1. Of the 159 initial hits
identified by the database search, 127 articles were excluded for not
using VBM or voxel-based analysis, by reading their abstracts. Of
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FIGURE 1 | Flow diagram of inclusion and exclusion criteria for the meta-analysis.
the remaining 32 articles, 25 did not meet the predefined inclusion
criteria (because of factors such as carrying out only white mat-
ter analysis, lack of information or data from relatives of patients
with schizophrenia, use of overlapping samples). The other seven
articles were shortlisted for using VBM to investigate GM changes
in patients, unaffected relatives, and healthy controls. However,
further investigation revealed that in one of the seven articles, the
relatives investigated were not from the investigated patients’ fam-
ilies, but from other families. The remaining six articles, together
with two articles identified from the reference lists, comprised the
final list of eight articles to be included. Seven of eight studies
included different types of first-degree relatives, namely, one of
monozygotic discordant twins (13), three of siblings (12, 14, 17),
two of parents (7, 15), one of both parents and siblings (6). Only
one study included the first- and second-degree of relatives (16).
Among the included articles, four utilized GM density while the
other four utilized GM volume to measure differences between
groups. A total of 495 patients with schizophrenia, 584 relatives
of patients, and 596 healthy controls were included. All of the
studies included both types of VBM comparison (i.e., patients vs.
controls and relatives vs. controls). In addition, Lui et al. (15)
distinguished patients with familial schizophrenia from patients
with sporadic illness and no family history. Thus, Lui et al. pro-
vided two VBM comparisons for each group, because the two
groups of patients and relatives were separately compared with
healthy controls. Consequently, each meta-analysis contained nine
datasets. The demographic characteristics of the patients, relatives
of patients with schizophrenia, and healthy controls are presented
in Tables 1 and 2.
THE RESULTS OF ES-SDM ANALYSIS
All of the nine VBM comparisons showed GM changes in patients
relative to the healthy controls. Compared to the healthy con-
trols, patients showed decreased GM in the right cuneus, the right
superior frontal gyrus, the right insula, and the left claustrum and
increased GM in the bilateral putamen, the right parahippocam-
pal gyrus, the left precentral gyrus, the left inferior temporal gyrus,
and the right cerebellar tonsil (Figure 2A; Table 3).
Four of the nine VBM comparisons showed no significant GM
changes in unaffected relatives of patients compared to healthy
controls (12, 13, 15, 16). The studies that showed significant GM
changes were comparable to the studies showing negative results
in terms of mean sample size of unaffected relatives [70.0± 81.89
vs. 57.75± 85.75 (P = 0.836)] and proportion of males [46.29 vs.
46.32% (P = 0.993)], but not for the mean age of the unaffected
relatives (37.32± 7.50 vs. 29.87± 5.16), which was significantly
different (P < 0.001). The results of the ES-SDM analysis from
the nine VBM comparisons are shown in Table 4 and Figure 2B.
Compared to healthy controls, unaffected relatives demonstrated
decreased GM in the left claustrum, the bilateral parahippocampal
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Table 1 | Demographic characteristics of the studies comparing schizophrenia patients and healthy controls.
Study Sample
size
Age in years (SD) Male in
proportions (%)
GM types
ofVBM
MRI
strength
Smoothing
FWHM
Medication
Pat Con Pat Con Pat Con
(17) 51 59 22.29 (3.95) 23.2 (2.58) 66.7 64.4 GM volume 3T 8 mm Nb
(6) 31 37 38.0 (11.24) 39.36 (9.97) 51.6 45.9 GM volume 3T 8 mm Y
(12) 155 122 26.91 (5.6) 27.5 (8.2) 80.65 50 GM density 1.5T 4 mm Y
(7) 30 30 22.63 (3.76) 22.77 (3.34) 56.7 60.0 GM density 3T 6 mm Y
(13) 9 34 33.8 (13.1) 39.3 (9.5) 66.7 70.6 GM volume 1.5T 8 mm Y
(15)a 10 10 22.0 (8.2) 23.0 (7.9) 50 50 GM density 3T 8 mm N
(15)a 10 10 21.2 (7.5) 23.0 (7.9) 50 50 GM density 3T 8 mm N
(14) 169 212 36.39 (9.46) 33.31 (9.86) 78.2 48.6 GM volume 1.5T 10 mm Y
(16) 26 49 36.85 (13.7) 35.27 (11.1) 50 46.9 GM density 1.5T 12 mm Y
(1) aTwo independent VBM comparisons between patients and healthy controls were conducted by Lui et al.
(2) bN, patients without medication; Y, patients medicated with antipsychotics.
(3) Pat, patients; Con, controls; SD, standard deviation; VBM, voxel-based morphometry; GM, gray matter; FWHM, full-width at half-maximum.
Table 2 | Demographic characteristics of the studies comparing relatives of patients with schizophrenia and healthy controls.
Study Sample
size
Age in years(SD) Male in
proportions (%)
Information of relatives GM types
ofVBM
MRI
strength
Smoothing
FWHM
Rel Con Rel Con Rel Con
(17) 45 59 22.6 (3.92) 23.2 (2.58) 64.4 64.4 First-degree (siblings) GM volume 3T 8 mm
(6) 29 37 40.38 (15.84) 39.36 (9.97) 48.3 45.9 First-degree (parents and siblings) GM volume 3T 8 mm
(12) 186 122 27.5 (6.8) 27.5 (8.2) 45.7 50 First-degree (siblings) GM density 1.5T 4 mm
(7) 55 29 50.31 (5.1) 51.79 (5.58) 49.1 48.3 First-degree (parents) GM density 3T 6 mm
(13) 9 34 33.8 (13.1) 39.3 (9.5) 66.7 70.6 First-degree (MZ) GM volume 1.5T 8 mm
(15)a 10 10 41.4 (3.7) 43.2 (6.3) 37.5 40 First-degree (parents) GM density 3T 8 mm
(15)a 10 10 45.6 (6.2) 43.2 (6.3) 41.7 40 First-degree (parents) GM density 3T 8 mm
(14) 213 212 36.5 (9.75) 33.31 (9.86) 41.8 48.6 First-degree (siblings) GM volume 1.5T 10 mm
(16) 24 49 38.92 (12.9) 35.27 (11.1) 45.8 46.9 First- and second-degree GM density 1.5T 12 mm
(1) aTwo independent VBM comparisons between relatives of patients and healthy controls were conducted by Lui et al.
(2) SD, standard deviation; MZ, monozygotic twins; VBM, voxel-based morphometry; GM, gray matter; FWHM, full-width at half-maximum.
gyri, the left fusiform gyrus, the right inferior temporal gyrus, and
the bilateral medial prefrontal cortices and increased GM in the
right hippocampus, the right fusiform gyrus, the right precentral
gyrus, and the right precuneus (Figure 2B).
DISCUSSION
Using ES-SDM meta-analysis of VBM studies in schizophrenia
patients and their unaffected relatives, the current study con-
firmed that schizophrenia patients and their unaffected relatives
share brain abnormalities, including reduced GM in the left claus-
trum and increased GM in the right fusiform gyrus. However, the
patients also showed other deficits, including decreased GM in the
right cuneus, the right superior frontal gyrus, and the right insula,
as well as increased GM in the bilateral putamen, the right parahip-
pocampal gyrus, the left precentral gyrus, the left inferior temporal
gyrus, and the right cerebellar tonsil (Table 3). Their unaffected
relatives also demonstrated reduced GM in other regions includ-
ing the bilateral parahippocampal gyri, the left fusiform gyrus,
the right inferior temporal gyri, and the medial prefrontal cortices
and increased GM in the right hippocampus, the right precentral
gyrus, and the right precuneus (Table 4). Thus, the current study
provides evidence to support the hypothesis that GM changes in
schizophrenia patients and their unaffected relatives are largely
different, but share some subtle overlap.
One of the most interesting findings of the present meta-
analysis is that both schizophrenia patients and their unaffected
relatives shared GM changes in the left claustrum and the right
fusiform gyrus, suggesting subtle genetic anatomical brain deficits
in schizophrenia. In fact, the claustrum belongs to the basal gan-
glia which plays a critical role in the cortical-subcortical model
for the pathogenesis of schizophrenia, in which prefrontal cortex
dysfunction leads to disinhibited dopaminergic activity, enhanced
subcortical dopamine neurotransmission in the basal ganglia, and
psychosis (23, 24). The shared deficits of the basal ganglia in both
patients and relatives suggest a genetic structural trait of schizo-
phrenia, possibly reflecting endogenous overactivity of the striatal
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FIGURE 2 | Gray matter differences between patients (A) and relatives of patients (B) compared with healthy controls. Areas with increased gray matter
relative to controls are displayed in red, and areas with decreased gray matter are displayed in blue.
dopamine system (25). Thus, the deficits of the basal ganglia may
be a core feature and a risk factor for the schizophrenia. (26)
However, another possible reason for the increase GM volume
of the basal ganglia in schizophrenia patients was related to the
antipsychotic treatment which was reported to be the target of
antipsychotic medication and found increased volume after treat-
ment (27). The increased GM volume in the fusiform gyrus in both
patients and relatives has seldom been reported and may represent
a protective or compensatory phenomenon. The function of the
right fusiform gyrus have been implicated in face-processing tasks
requiring perception of faces and objects (28). In fact, the func-
tional deficits of the right fusiform gyrus were also reported in both
schizophrenia patients and their siblings, and these abnormalities
could reflect reduced language-related lateralization in individu-
als with schizophrenia and their high-risk siblings (29). Another
previous study indicated that loss of fusiform gyrus volume was
negatively correlated with improvement in neurocognitive func-
tion as well as social cognition (30). Our study provided further
evidences to support the possible genetic related GM changes of
the right fusiform in schizophrenia.
However, it should be noted that the shared changes of GM vol-
ume are subtle, which suggests that the anatomical correlates of
genetic liability may be small. Therefore, it may be not possible to
pinpoint any single factor as being by itself necessary and sufficient
to cause a psychiatric disorder. Most likely, the affected patients
have multiple risk factors in different combinations that vary indi-
vidually from patient to patient (31). Thus, heightened genetic risk
for the unaffected first-degree relatives of schizophrenia may be
reflected in small changes to cognitive functioning (9), as well as in
brain structural changes. Schizophrenia is thought to result from
a combination of multiple factors, such as genes, environment,
antipsychotics, substance abuse, and comorbidities. However, Lui
et al. observed that familial parents have more neuroanatomical
abnormalities than sporadic parents (15). Furthermore, brain vol-
ume differences in twins discordant for schizophrenia were more
pronounced in monozygotic than in dizygotic twins, compared
with healthy control twins (32–34). This evidence suggests that the
genetic contribution to brain volume alterations in schizophrenia
may be subtle but prominent in subjects with a high genetic load,
i.e., monozygotic discordant twins or familial parents rather than
healthy siblings of patients with schizophrenia. In addition, one
single factor could have multiple effects. Thus, a single gene could
cause different phenotypes, depending on various interactions at
the gene–gene and gene-environmental levels (genetic pleiotro-
pism) (31). This theory is supported by recent studies that reported
that the same genetic variants can cause both bipolar disorder and
schizophrenia (35, 36). Furthermore, the shared GM in the left
claustrum could be regarded with suspicion as this deep GM area
is rather delicate and thus might be prone to image-registration
errors.
It should also be noted that the most common deficits in GM
volume in the patient group involved the cortical-striatal regions,
which is consistent with a previous meta-analysis (2). The superior
frontal gyrus, which showed reduced GM volume in our study,
belongs to the prefrontal cortex, which is frequently thought to
be a key structure in schizophrenia. The superior frontal gyrus
plays an important role in managing many executive functions,
such as working memory, response inhibition, and goal-directed
behaviors. These cognitive abilities are typically disturbed in schiz-
ophrenia. In line with previous volumetric studies (37), we also
found decreased GM in the insula, which has been suggested to
be linked to clinical features such as reality distortion (38). In
addition to the decreased GM, increased GM was also revealed in
the patient group in the bilateral basal ganglia, the right fusiform
gyrus, the left inferior temporal gyrus, the left precentral gyrus,
and the right cerebellar tonsil. These findings are not surprising,
as increased GM volume has also been reported in previous stud-
ies (39–42). A recent study of the largest sample of drug-naive
first-episode of schizophrenia patients also revealed wide-spread
increases in GM (42). The increased GM in the basal ganglia was
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Table 3 | Gray matter differences between patients and healthy controls.
Regions Maximum Cluster Cluster breakdown Jack-knife sensitivity
Talairach
coordinates
Z
value
Uncorrected
P
No. of
voxels
No. of analyses survived
by the clusters
PATIENTS>CONTROLS
Right basal ganglia (Right
lentiform nucleus, putamen)
20, 2, 4 2.287 0.000064226 85 Right putamen 9 out of 9
Right caudate body
Right caudate head
Right lateral globus pallidus
Left basal ganglia (Left
lentiform nucleus, putamen)
−22, −2, 8 2.283 0.000064226 77 Left putamen 8 out of 9
Left caudate body
Left lateral globus pallidus
Right parahippocampal gyrus 38, −26, −16 2.140 0.000166988 43 Right parahippocampal gyrus 8 out of 9
Right inferior temporal gyrus
Right fusiform gyrus
Left precentral gyrus −38, −8, 46 2.055 0.000616570 21 Left precentral gyrus 8 out of 9
Left middle frontal gyrus
Left inferior temporal
gyrus(Left fusiform gyrus)**
−46, −12, −30 2.053 0.000616570 36 Left inferior temporal gyrus 8 out of 9
Left fusiform gyrus
Right cerebellar tonsil 22, −54, −34 1.831 0.002581888 13 Right cerebellar tonsil 7 out of 9
PATIENTS<CONTROLS
Right cuneus 22, −98, −2 −3.877 0.000321130 90 Right cuneus 8 out of 9
Right lingual gyrus
Right middle occipital gyrus
Right inferior occipital gyrus
Right superior frontal gyrus 28, 60, 4 −3.645 0.000552344 78 Right superior frontal gyrus 7 out of 9
Right middle frontal gyrus
Right insula 42, 2, 12 −3.179 0.001451509 40 Right insula 8 out of 9
Right superior temporal gyrus
Right precentral gyrus
Left basal ganglia (Left
clastrum)**
−30, 16, 2 −3.132 0.001592807 49 Left clastrum 7 out of 9
Left superior temporal gyrus
Left insula
Left extra-nuclear
**Shared GM alterations in patients and their unaffected relatives.
consistent with most of the findings in an independent study
of schizophrenia patients (43, 44). However, negative findings
(45) or even decreased volumes of basal ganglia (46) GM have
also been reported. The increased putamen GM may be partly
attributed to exposure to antipsychotic medication, which is sup-
ported by the results of recent studies that showed increased
putamen (47, 48) in first-episode drug-naïve schizophrenics after
several weeks of antipsychotic treatment. Most studies included
in the present meta-analysis investigated medicated schizophrenia
patients, except for two studies (15, 17). Thus, the increased GM
reported here could be related to antipsychotics.
Unlike the consistently positive findings in the patient groups,
nearly half of the VBM comparisons (four out of nine) did not
find structural differences between unaffected relatives and healthy
controls. This finding suggests that the anatomical correlates of
genetic liability may be weak. However, another possible reason
for the negative findings in relatives is that the moderate changes
in the relatives may be missed when using VBM (38). Our results
of unaffected relatives are mostly consistent with Palaniyappan
et al., who performed a meta-analysis of VBM studies seeking
to identify the neuroanatomical correlates of genetic liability in
schizophrenia. Though the primary studies that were pooled in
that meta-analysis largely overlap with the studies that we iden-
tified, there are some important differences. We did not include
Job et al. (49) or Marcelis et al. (50) in the present meta-analysis,
as the unaffected relatives and schizophrenia patients in those two
studies came from different families; thus, the patients and unaf-
fected relatives shared no biological relationship. Furthermore,
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Table 4 | Gray matter differences between relatives of patients with schizophrenia and healthy controls.
Regions Maximum Cluster Cluster breakdown Jack-knife sensitivity
Talairach
coordinates
Z
value
Uncorrected
P
No. of
voxels
No. of analyses survived
by the clusters
RELATIVES>CONTROLS
Right hippocampus 24, −20, −20 2.219 0.000051381 59 Right parahippocampus 8 out of 9
Right hippocampus
Right fusiform gyrus** 44, −30, −20 2.200 0.000077071 71 Right fusiform gyrus 8 out of 9
Right inferior temporal gyrus
Right parahippocampus
Right precentral gyrus 56, 2, 28 2.168 0.000089917 135 Right precentral gyrus 8 out of 9
Right inferior temporal gyrus
Right middle temporal gyrus
Right precuneus 10, −60, 32 1.902 0.000924855 73 Right precuneus 8 out of 9
Right cingulate gyrus
RELATIVES<CONTROLS
Left basal ganglia (claustrum)** −34, −4, −6 −2.549 ∼0 81 Left lentiform nucleus, putamen 8 out of 9
Left claustrum
Left parahippocampal gyrus
Left insula
Right parahippocampal gyrus 26, −48, −4 −2.405 0.000051381 77 Right parahippocampal gyrus 8 out of 9
Right fusiform nucleus
Right declive
Right culmen
Left fusiform gyrus −52, −42, −22 −2.144 0.000488118 52 Left fusiform gyrus 8 out of 9
Left inferior temporal gyrus
Left tuber
Bilateral medial prefrontal gyri 2, 58, 2 −2.029 0.000873475 51 Right medial frontal gyrus 7 out of 9
Left medial frontal gyrus
Right inferior temporal gyrus 42, −64, −16 −1.950 0.001207405 53 Right declive 8 out of 9
Right fusiform gyrus
Left parahippocampal gyrus −26, −54, −6 −1.919 0.001374438 16 Left parahippocampal gyrus 8 out of 9
Left fusiform gyrus
**Shared GM alterations in patients and their unaffected relatives.
we included two other recently published studies (6, 17). The
studies that showed significant GM changes were comparable to
the studies showing negative results in terms of mean sample size
of unaffected relatives and proportion of males, but the mean age
of unaffected relatives was different.
Unexpectedly, the present meta-analysis of unaffected relatives
also displayed wide-spread GM changes throughout the whole-
brain (Table 4), though many areas are different from those of
the patients. The left claustrum, the bilateral parahippocampal
gyri, the left fusiform gyrus, the right inferior temporal gyrus
and the bilateral medial prefrontal cortices emerged as the most
significant loci with GM reductions in unaffected relatives com-
pared to controls. The GM reduction was qualitatively consis-
tent with some liability literature. For example, GM decreases
in the parahippocampal gyrus and the medial prefrontal gyrus
have been reported in previous studies of unaffected relatives of
schizophrenia patients (13, 16, 51). The parahippocampal region
is considered to be a part of the limbic lobe. Together with the
amygdala, the parahippocampal gyrus assumes an important role
in emotional processing and goal-directed processes (52). Fur-
thermore, a recent functional study also provided evidence that
hippocampal-parahippocampal dysfunction is related to genetic
risk of developing schizophrenia (53). Our meta-analysis, however,
did not find a grossly decreased volume of the hippocampus, which
is has been reported as a pronounced change in non-psychotic
first-degree relatives of schizophrenia patients in previous studies
using ROI analysis (10). However, the conclusion of the previ-
ous meta-analysis was strongly influenced by a publication bias
that most studies selectively measured morphometric changes in
the hippocampus. Thus, the discrepancy may partly result from
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the different methods. VBM provides an unbiased approach to
establish the presence of regional changes in GM by surveying the
whole-brain.
The regions that displayed GM increases, the right parahip-
pocampus, the right fusiform gyrus, the right precentral gyrus,
and the right precuneus, have been reported in previous studies.
Increased volume of the bilateral parahippocampal gyrus and the
temporal lobe (though middle temporal) have been reported in
unaffected relatives of patients with schizophrenia (51, 54). Fur-
thermore, Seidman et al. (55) found increased cerebral volume
in a small group of relatives. Though the exact mechanism for
these increases is still unknown, it is possible that they may repre-
sent a protective or compensatory mechanism in unaffected family
members, although this hypothesis is highly speculative (14). To
better understand brain structure changes between patients with
schizophrenia and their unaffected relatives, substantial effort is
needed to search for biomarkers associated with robust genetic
liability.
We acknowledge several limitations of the current meta-
analysis. First, the small sample size may limit the power of our
analyses, in particular sub-analyses of groups at differential genetic
risk for psychosis (i.e., first-degree relatives vs. twins). Another
limitation is related to the VBM methodology. Although VBM
provides an unbiased approach to investigate the GM differences
throughout the brain, its limitations relate to the difficulty of spa-
tially normalizing brains, the robustness of standard parametric
tests, and the interpretation of the results (56). A recent study sug-
gested that subtle surface anatomical changes may be important for
the pathophysiology of schizophrenia, and these changes may be
missed when using VBM (38). Furthermore, both GM density and
volume were used in the included eight studies. Though the differ-
ence of density and volume were little for VBM study, we cannot
exclude the possible bias caused by the approaches. Finally, most of
the patients included in the present meta-analysis were medicated.
Thus, it is impossible to exclude the influence of antipsychotics on
brain morphology. Cross-sectional (20) study which compared
genetic high-risk subjects and first-episode antipsychotic-naive
schizophrenia patients or longitudinal design (57) of high-risk
subjects who finally translate to psychosis will help to analysis the
genetic liability to psychosis.
Altogether, the current meta-analysis shows wide-spread GM
deficits, including increased and decreased GM in both schizo-
phrenia patients and their unaffected biological relatives. How-
ever, patients and relatives only showed subtle overlap, suggest-
ing that the anatomical correlates of genetic liability may be
weak for schizophrenia. As limitations such as small sample
size and medication status could affect the findings, the rela-
tionship between GM deficits and susceptibility to developing
schizophrenia remains to be established. In the future, studies
of antipsychotic-naïve patients with first-episode schizophrenia
and their unaffected relatives may help to clarify the genetic and
environmental susceptibility to schizophrenia.
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